Price$3.42+0.00 (+0.00%)
06:15 PM07:00 PM
News · 26 weeks16-100%
2025-12-142026-06-07
Mix1490d
- SEC Filings5(36%)
- Insider4(29%)
- Earnings3(21%)
- Other1(7%)
- Leadership1(7%)
Latest news
25 items- SECNephros Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - NEPHROS INC (0001196298) (Filer)
- PRNephros Announces Financial Results for Quarter Ended March 31, 2026SOUTH ORANGE, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the first quarter ended March 31, 2026. Financial Highlights Net revenue was $5.2 million, compared to $4.9 million in the first quarter of 2025, up 7%Net income was $140,000, compared to a net income of $558,000 in the first quarter of 2025Adjusted EBITDA was $206,000, compared to $667,000 in the first quarter of 2025 "Q1 2026 represents another important milestone for Nephros, as we exceeded $5 million in revenue in a quarter the first time in our company's histor
- SECSEC Form 10-Q filed by Nephros Inc.10-Q - NEPHROS INC (0001196298) (Filer)
- SECAmendment: SEC Form 10-K/A filed by Nephros Inc.10-K/A - NEPHROS INC (0001196298) (Filer)
- PRNephros Schedules First Quarter 2026 Financial Results Conference CallSOUTH ORANGE, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Thursday, May 07, 2026 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page. Alternatively, a replay of th
- PRNephros Expands Strategic Focus in Greater New York Market with Dedicated Regional LeadershipSOUTH ORANGE, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced an expansion of its strategic focus in the Greater New York City region with the addition of Dana Cunningham as a dedicated regional sales leader. The Greater New York market represents one of the most densely populated and infrastructure-intensive regions in the United States, with a high concentration of healthcare facilities, aging water systems, and increasing regulatory and operational focus on waterborne pathogen risk. Based on internal estimates, Nephros believes this region repre
- PRNephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning ExpertiseSOUTH ORANGE, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced an expansion of its customer-facing, water-safety support capabilities following the ASSE 12080 Legionella Water Safety and Management Specialist Certification earned by Brianne McGuire, Director of Business Development. The certification strengthens Nephros' ability to provide consultative support to healthcare facilities and other complex buildings seeking to reduce waterborne pathogen risk and adds specific proficiency in the development of effective Water Management Programs (WMPs).
- SECNephros Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - NEPHROS INC (0001196298) (Filer)
- INSIDERSEC Form 4 filed by Banks Robert R. Jr.4 - NEPHROS INC (0001196298) (Issuer)
- INSIDERSEC Form 4 filed by Krandel Judy4 - NEPHROS INC (0001196298) (Issuer)
- INSIDERSEC Form 4 filed by Nephros Inc.4 - NEPHROS INC (0001196298) (Issuer)
- INSIDERSEC Form 4 filed by Krandel Judy4 - NEPHROS INC (0001196298) (Issuer)
- PRNephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial ResultsFull-Year Net Revenue Increased 33% Y-O-Y to $18.8 Million and Fourth-Quarter Net Revenue up 22% Y-O-Y to $4.7 Million Reports Second Consecutive Year of Positive Net Income SOUTH ORANGE, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2025. Financial HighlightsFourth Quarter Ended December 31, 2025. Net revenue was $4.7 million, compared to $3.9 million in the fourth quarter of 2024, up 22%Net income was $62,000, compared to $349,000 during the same period in 2024Adjust
- SECSEC Form 10-K filed by Nephros Inc.10-K - NEPHROS INC (0001196298) (Filer)
- PRNephros Schedules Fourth Quarter 2025 Financial Results Conference CallSOUTH ORANGE, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth-quarter financial results on Thursday, March 12, 2026 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page. Alternatively, a replay of
- PRNephros Expands into Puerto Rico to Deliver Differentiated Water Filtration Solutions Across Medical and Commercial SectorsSOUTH ORANGE, N.J., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced its entry into the Puerto Rican market, targeting high-need applications such as ice machines, drinking fountains, bottle fillers, and sterile processing environments. With a proven track record in infection control and water purity, Nephros brings a differentiated approach to water filtration, delivering advanced products with faster service and local-language support in a region long underserved by premium filtration providers. Puerto Rico MarketWith increasing focus on public health,
- PRNephros Launches the Nephros Water Institute to Lead National Water Safety EducationSOUTH ORANGE, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leader in point-of-use water filtration, today announced the launch of the Nephros Water Institute, a dedicated education initiative established to formalize the company's leadership in industry education. In 2025, Nephros accelerated its national education efforts under the direction of Brianne McGuire, Director of Business Development. Through high-engagement public webinars, national speaking engagements, and tailored trainings with healthcare systems and consulting partners, Nephros directly reached nearly 1,000 professionals. The regulatory and risk-based educational programming addressed critical bl
- SECNephros Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement8-K - NEPHROS INC (0001196298) (Filer)
- INSIDERDirector Nettis Lisa Marie was granted 1,622 shares (SEC Form 4)4 - NEPHROS INC (0001196298) (Issuer)
- INSIDERDirector Spandow Oliver J. was granted 8,036 shares, increasing direct ownership by 7% to 122,881 units (SEC Form 4)4 - NEPHROS INC (0001196298) (Issuer)
- INSIDERDirector Amron Arthur H was granted 5,391 shares, increasing direct ownership by 4% to 131,272 units (SEC Form 4)4 - NEPHROS INC (0001196298) (Issuer)
- PRNephros Announces Strong Third Quarter Financial Results; Achieving Highest Level of Programmatic Sales in Company HistoryThird-Quarter Net Revenue of $4.8 million; Robust Growth Drives 35% Increase in Net Revenue and Fourth Consecutive Quarter of Profitability SOUTH ORANGE, NJ., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2025. Financial Highlights Net revenue increased 35% to $4.8 million compared to $3.5 million in the third quarter of 2024Net income increased 84% to $337,000, compared to $183,000 in the third quarter of 2024Adjusted EBITDA increased 42% to $418,000, compared to $295,000 in the third quarte
- SECSEC Form 10-Q filed by Nephros Inc.10-Q - NEPHROS INC (0001196298) (Filer)
- PR¬Nephros Schedules Third Quarter 2025 Financial Results Conference CallSOUTH ORANGE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Thursday, November 6, 2025 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page. Alternatively, a replay of
- PRNephros Launches New PFAS Filter for Point-of-Use Protection of Potable WaterSOUTH ORANGE, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to medical and commercial markets, today announced the launch of its new filter designed to reduce Total PFAS, or per- and polyfluoroalkyl substances (PFAS), in potable water. This product expands Nephros' portfolio to address a category of chemical contaminants that have drawn growing regulatory and public health attention. PFAS, sometimes referred to as "forever chemicals," are synthetic compounds found in a wide range of consumer and industrial products. They are notable for their persistence in the environment, as well as their bioaccumul
NEPH FAQ
5 questionsWhat does Nephros Inc. do?
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company operates through three segments: Water Filtration, Pathogen Detection, and Renal Products. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company develops and...Where does NEPH stock trade?
Nephros Inc. (NEPH) is listed on NASDAQ.What sector and industry is NEPH in?
Nephros Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What companies are similar to NEPH?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare NEPH side-by-side with any of them on Quantisnow.How can I track NEPH on Quantisnow?
Quantisnow aggregates Nephros Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NEPH to receive live email and push alerts on every new disclosure.